iNtRON Biotechnology Inc (048530) — Cash Flow Quality Index
iNtRON Biotechnology Inc (048530) has a Cash Flow Quality Index of -4.73x as of June 2024. Operating cash flow of ₩-2.74 Billion is below net income of ₩579.25 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 048530 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
iNtRON Biotechnology Inc Cash Flow Quality Index (2015–2022)
Historical Cash Flow Quality Index for iNtRON Biotechnology Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of iNtRON Biotechnology Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for iNtRON Biotechnology Inc (2015–2022)
Year-by-year earnings quality comparison for iNtRON Biotechnology Inc. For live market cap and the full company financial profile, see iNtRON Biotechnology Inc market cap and net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.05x | ₩5.98 Billion | ₩5.71 Billion | ▼ -38.2% |
| 2021 | 1.69x | ₩16.47 Billion | ₩9.73 Billion | ▲ +255.0% |
| 2020 | 0.48x | ₩7.13 Billion | ₩14.95 Billion | ▼ -1.1% |
| 2018 | 0.48x | ₩4.20 Billion | ₩8.71 Billion | ▼ -55.8% |
| 2015 | 1.09x | ₩1.70 Billion | ₩1.56 Billion | — |